382637-99-2

Basic information

• Product Name: Carbamic acid, (5-acetyl-4-methyl-2-thiazolyl)-, phenyl ester
• CAS NO: 382637-99-2
• Molecular Formula: C13H12N2O3S
• Molecular Weight: 276.316
• Mol File: 382637-99-2.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (5-acetyl-4-methyl-2-thiazolyl)-, phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (5-acetyl-4-methyl-2-thiazolyl)-, phenyl ester(382637-99-2)
• EPA Substance Registry System: Carbamic acid, (5-acetyl-4-methyl-2-thiazolyl)-, phenyl ester(382637-99-2)

Safety Data

• Hazardous Substances Data: 382637-99-2(Hazardous Substances Data)

Upstream product

• 102-09-0 bis(phenyl) carbonate 
• 30748-47-1 5-acetyl-4-methylthiazole-2-amine 
• 1885-14-9 phenyl chloroformate 
• 1694-29-7 3-chloropentane-2,4-dione 

Downstream Products

• 275812-32-3 1-(5-Acetyl-4-methyl-thiazol-2-yl)-3-{(1R,2S)-2-[(S)-3-(4-fluoro-benzyl)-piperidin-1-ylmethyl]-cyclohexyl}-urea 
• 388109-48-6 (3S,4S)-3-amino-4-[(S)-3-(4-fluorobenzyl)-piperidin-1-ylmethyl]-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 388097-48-1 (3R,4R)-4-[3-(5-acetyl-4-methyl-thiazol-2-yl)-ureido]-3-[(S)-3-(4-fluoro-benzyl)-piperidin-1-ylmethyl]-piperidine-1-carboxylic acid t-butyl ester 
• 388101-50-6 C₃₀H₄₂FN₅O₄S 
• 388105-01-9 C₂₉H₄₀FN₅O₄S 
• 676621-35-5 1-(5-acetyl-4-methylthiazol-2-yl)-3-{1-[2-(4-fluorophenyl)ethyl]-piperidin-3-ylmethyl}urea 
• 503186-98-9 N-(5-Acetyl-4-methyl-thiazol-2-yl)-N'-{(1R,2S)-2-[(5S)-5-(4-fluoro-benzyl)-3-oxo-piperazin-1-yl-methyl]-cyclohexyl}-urea 
• 935853-15-9 1-(5-acetyl-4-methylthiazol-2-yl)-3-{4-[(4-fluorobenzyl)methylamino]butyl}urea 
• 1020321-60-1 N-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide 
• 852660-68-5 N-(5-acetyl-4-methyl-thiazol-2-yl)-N'-[(1R,2S,5R)-5-(N-methyl)acetamido-2-[N-methyl-3-(4-fluorophenyl)propylamino]methyl-cyclohexyl]urea 
• 852660-69-6 N-(5-acetyl-4-methyl-thiazol-2-yl)-N'-[(1R,2S,5S)-5-(N-methyl)acetamido-2-[N-methyl-3-(4-fluorophenyl)propylamino]methyl-cyclohexyl]urea 
• 852660-83-4 N-((1R,3R,4S)-3-({[(5-acetyl-4-methyl-1,3-thiazol-2-yl)amino]carbonyl}amino)-4{[3-(4-fluorophenyl)propyl(propyl)amino]methyl}cyclohexyl)-N-methylacetamide 
• 852660-84-5 N-((1S,3R,4S)-3-({[(5-acetyl-4-methyl-1,3-thiazol-2-yl)amino]carbonyl}amino)-4{[3-(4-fluorophenyl)propyl(propyl)amino]methyl}cyclohexyl)-N-methylacetamide 

Relevant articles and documents

Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases

Enteroviruses (EVs) are among the most frequent infectious agents in humans worldwide and represent the leading cause of upper respiratory tract infections. No drugs for the treatment of EV infections are currently available. Recent studies have also linked EV infection with pulmonary exacerbations, especially in cystic fibrosis (CF) patients, and the importance of this link is probably underestimated. The aim of this work was to develop a new class of multitarget agents active both as broad-spectrum antivirals and as correctors of the F508del-cystic fibrosis transmembrane conductance regulator (CFTR) folding defect responsible for >90% of CF cases. We report herein the discovery of the first small molecules able to simultaneously act as correctors of the F508del-CFTR folding defect and as broad-spectrum antivirals against a panel of EVs representative of all major species.

Stereoselective process for a CCR3 antagonist

A convergent, multikilogram, stereoselective synthesis of 1 is described. A key fragment, (S)-3-(4-fluorobenzyl)piperidine (2) was synthesized from valerolactam in three steps using our recently discovered Ir-BDPP-catalyzed asymmetric hydrogenation. Anoth

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

The present application describes modulators of chemokine receptor activity of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases, as well as autoimmune pathologies such as rheum